Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Call Options Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$359 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$213 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$167 Million2.47% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$90.9 Million0.11% of portfolio
-
State Street Corp Boston, MA2.19MShares$75.7 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.85B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...